Marex Group plc Announces Launch of a Public Offering
22 October 2024 - 7:52AM
Marex Group plc (Nasdaq: MRX) (“Marex”), the diversified global
financial services platform, today announces the launch of a public
offering of its ordinary shares (the “Offering”) by certain selling
shareholders (the “Selling Shareholders”). The Selling Shareholders
are offering a total of 7,000,000 ordinary shares. In connection
with the Offering, the Selling Shareholders have granted the
underwriters a 30-day option to purchase up to an additional
1,050,000 ordinary shares.
Marex is not selling any ordinary shares in the
Offering and will not receive any proceeds from the sale of shares
by the Selling Shareholders.
Barclays, Goldman Sachs & Co. LLC,
Jefferies, and Keefe, Bruyette & Woods, a Stifel Company, are
acting as joint lead book-running managers and as representatives
of the underwriters for the proposed Offering.
The proposed Offering will be made only by means
of a prospectus. Copies of the preliminary prospectus relating to
the proposed Offering may be obtained from:
- Barclays Capital Inc., c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
NY 11717, by telephone at 1-888-603-5847, or by email at
barclaysprospectus@broadridge.com;
- Goldman Sachs & Co. LLC,
Attention: Prospectus Department, 200 West Street, New York, New
York 10282, via telephone: 1-866-471-2526, or via email:
prospectus-ny@ny.email.gs.com;
- Jefferies LLC, Attention: Equity
Syndicate Prospectus Department, 520 Madison Avenue, New York, NY
10022, by phone at (877) 821-7388, or by email at
Prospectus_Department@Jefferies.com; or
- Keefe, Bruyette & Woods Inc.,
787 Seventh Avenue, Fourth Floor, New York, NY 10019, attention:
Equity Capital Markets, or by calling toll free at (800) 966-1559
or emailing USCapitalMarkets@kbw.com.
A registration statement relating to these
securities has been filed with the U.S. Securities and Exchange
Commission but has not yet become effective. These securities may
not be sold, nor may offers to buy these securities be accepted,
prior to the time the registration statement becomes effective.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities, and shall not
constitute an offer, solicitation or sale in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of that
jurisdiction.
Enquiries please contact:
Nicola Ratchford / Robert Coates
Marex
+44 (0) 7786548889 / +44 (0) 7880486329 | nratchford@marex.com / rcoates@marex.com
FTI Consulting US / UK
+1 (919) 609-9423 / +44 (0) 7776111222 | marex@fticonsulting.com
Marex (NASDAQ:MRX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Marex (NASDAQ:MRX)
Historical Stock Chart
From Nov 2023 to Nov 2024